01 1Aurisco Pharmaceutical
01 1RELUGOLIX
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-24
Pay. Date : 2024-07-08
DMF Number : 38488
Submission : 2024-07-05
Status : Active
Type : II
20
Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is RELUGOLIX, with a corresponding US DMF Number 38488.
Remarkably, this DMF maintains an Active status since its submission on July 05, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 24, 2024, and payment made on July 08, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
